Showing 1 - 20 results of 30 for search '"невнимательность"', query time: 1.08s Refine Results
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
    Academic Journal

    Source: Сучасні інформаційні системи, Vol 3, Iss 3 (2019)
    Сучасні інформаційні системи; Том 3 № 3 (2019): Сучасні інформаційні системи; 76-81
    Advanced Information Systems; Vol. 3 No. 3 (2019): Advanced Information Systems; 76-81
    Современные информационные системы-Sučasnì ìnformacìjnì sistemi; Том 3 № 3 (2019): Современные информационные системы; 76-81

    File Description: application/pdf

  6. 6
  7. 7
  8. 8
    Academic Journal
  9. 9
  10. 10
    Academic Journal

    Source: Russian Journal of Child Neurology; Vol 13, No 3 (2018); 57-73 ; Русский журнал детской неврологии; Vol 13, No 3 (2018); 57-73 ; 2412-9178 ; 2073-8803

    File Description: application/pdf

  11. 11
    Academic Journal

    Source: Russian Journal of Child Neurology; Том 10, № 2 (2015); 59-71 ; Русский журнал детской неврологии; Том 10, № 2 (2015); 59-71 ; 2412-9178 ; 2073-8803 ; 10.17650/2073-8803-2015-10-2

    File Description: application/pdf

    Relation: https://rjdn.abvpress.ru/jour/article/view/57/53; Брязгунов И.П., Гончарова О.В., Касатикова Е.В. Синдром дефицита внимания с гиперактивностью у детей: протокол лечения. Российский педиатрический журнал 2001;5:34–6. [Bryazgunov I.P., Goncharova O.V., Kasatikova E.V. Attention deficit hyperactivity disorder in children: treatment protocol. Rossiyskiy pediatricheskiy zhurnal = Russian Pediatric Journal 2001;5:34–6. (In Russ.)].; Воронкова К.В., Петрухин А.С., Пылаева О.А., Холин А.А. Рациональная антиэпилептическая фармакотерапия. М.: Бином, 2007. 275 с. [Voronkova K.V., Petrukhin A.S., Pylaeva O.A., Kholin A.A. Rational antiepileptic drug treatment. Мoscow: Binom, 2007. 275 p. (In Russ.)].; Заваденко Н.Н. Гиперактивность и дефицит внимания в детском возрасте. М., 2005. 256 с. [Zavadenko N.N. Attention deficit hyperactivity disorder in childhood. Moscow, 2005. 256 p. (In Russ.)].; Заваденко Н.Н., Симашкова Н.В. Новые подходы к диагностике синдрома дефицита внимания и гиперактивности. Журнал неврологии и психиатрии им. С.С. Корсакова 2014;114(1, вып. 2):45–51. [Zavadenko N.N., Simashkova N.V. New approaches to diagnosis of attention deficit hyperactivity disorder. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova = S.S. Korsakov Journal of Neurology and Psychiatry 2014;114(1, issue 2):45–51. (In Russ.)].; Заваденко Н.Н., Соломасова А.А. Синдром дефицита внимания с гиперактивностью в сочетании с тревожными расстройствами: возможности фармакотерапии. Журнал неврологии и психиатрии им. С.С. Корсакова 2012;112(8):44–8. [Zavadenko N.N., Solomasova A.A. Attention deficit hyperactivity syndrome in combination with anxious disorders: possibilities of drug treatment. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova = S.S. Korsakov Journal of Neurology and Psychiatry 2012;112(8): 44–8. (In Russ.)].; Зенков Л.Р., Константинов П.А., Ширяева И.Ю. и др. Психические и поведенческие расстройства при идиопатических эпилептиформных фокальных разрядах. Журнал неврологии и психиатрии им. С.С. Корсакова 2007;107(6):39–49. [Zenkov L.R., Konstantinov P.A., Shiryaeva I.Yu. et al. Mental and behaviour disorders at idiopathic epileptiform localized discharges. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova = S.S. Korsakov Journal of Neurology and Psychiatry 2007;107(6):39– 49. (In Russ.)].; Инструкция по медицинскому применению препарата Глицин. [Guidelines for medical use of glycine. (In Russ.)].; Карлов В.А. Эпилепсия у детей и взрослых женщин и мужчин. М.: Медицина, 2010. С. 543–62. [Karlov V.A. Epilepsy in children and adult women and men. Мoscow: Meditsina, 2010. Pp. 543–62. (In Russ.)].; Мухин К.Ю., Миронов М.Б., Петрухин А.С. Эпилептические синдромы. Диагностика и терапия. 3-е изд. М.: ООО «Системные решения», 2014. С. 353–64. [Mukhin K.Yu., Mironov M.B., Petrukhin А.S. Epileptic syndromes. Diagnosis and therapy. 3rd ed. Moscow: Systemnye resheniya LLC, 2014. Pp. 353–64. (In Russ.)].; Пылаева О.А., Воронкова К.В., Петрухин А.С. и др. Эпилепсия и синдром дефицита внимания и гиперактивности (обзор литературы). Вестник эпилептологии 2011;1:3–15. [Pylaeva О.A., Voronkova K.V., Petrukhin A.S. et al. Epilepsy and attention deficit hyperactivity disorder (literature review). Vestnik epileptologii = Bulletin of Epileptology 2011;1:3–15. (In Russ.)].; Пылаева О.А., Воронкова К.В., Петрухин А.С. Эффективность и безопасность антиэпилептической терапии у детей (сравнительная оценка препаратов вальпроевой кислоты и барбитуратов). Журнал неврологии и психиатрии им. С.С. Корсакова 2004;8:61–5. [Pylaeva O.A., Voronkova K.V., Petrukhin A.S. Efficacy and safety of antiepileptic therapy in children (valproic acid drugs vs. barbiturates). Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova = S.S. Korsakov Journal of Neurology and Psychiatry 2004;8:61–5. (In Russ.)].; Холин А.А., Ильина Е.С. Сочетание эпилепсии с синдромом дефицита внимания и гиперактивности (клинические примеры). Вестник эпилептологии 2011;1:16– 22. [Kholin A.A., Ilyina E.S. Combination of epilepsy and attention deficit hyperactivity disorder (clinical examples). Vestnik epileptologii = Bulletin of Epileptology 2011;1:16–22. (In Russ.)].; Aldenkamp A.P., Arzimanoglou A., Reijs R., Van Mil S. Optimizing therapy of seizures in children and adolescents with ADHD. Neurology 2006;67(12 Suppl 4): 49–51.; Barabas G., Matthews W.S. Barbiturate anticonvulsants as a cause of severe depression. Pediatrics 1988;82(2):284–5.; Barkley R.A. Attention-deficit hyperactivity disorder. Sci Am 1998;279(3): 66–71.; Barkley R.A. How should attention deficit disorder be described? Harv Ment Health Lett 1998;14(8):8.; Becker K., Sinzig J.K., Holtmann M. Attention deficits and subclinical epileptiform discharges: are EEG diagnostics in ADHD optional or essential? Dev Med Child Neurol 2004;46(6):431–2.; Brown R.T., Freeman W.S., Perrin J.M. et al. Prevalence and assessment of attentiondeficit/hyperactivity disorder in primary care settings. Pediatrics 2001;107(3):E43.; Bymaster F.P., Katner J.S., Nelson D.L. et al. Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: a potential mechanism for efficacy in attention deficit/ hyperactivity disorder. Neuropsychopharmacology 2002;27(5): 699–711.; Caplan R., Siddarth P., Stahl L. et al. Childhood absence epilepsy: behavioral, cognitive, and linguistic comorbidities. Epilepsia 2008;49(11):1838–46.; Chadwick D., Marson T. Choosing a first drug treatment for epilepsy after SANAD: randomized controlled trials, systematic reviews, guidelines and treating patients. Epilepsia 2007;48(7):1259–63.; Cramer J.A., Hammer A.E., Kustra R.P. Improved mood states with lamotrigine in patients with epilepsy. Epilepsy Behav 2004;5(5):702–7.; D'Agati E., Moavero R., Cerminara C., Curatolo P. Attention-deficit hyperactivity disorder (ADHD) and tuberous sclerosis complex. J Child Neurol 2009;24(10): 1282–7.; Davis S.M., Katusic S.K., Barbaresi W.J. et al. Epilepsy in children with attentiondeficit/hyperactivity disorder. Pediatr Neurol 2010;42(5):325–30.; de Vries P.J., Gardiner J., Bolton P.F. Neuropsychological attention deficits in tuberous sclerosis complex (TSC). Am J Med Genet A 2009;149A(3):387–95.; Depositario-Cabacar D.F., Zelleke T.G. Treatment of epilepsy in children with developmental disabilities. Dev Disabil Res Rev 2010;16(3):239–47.; Duane D.D. Increased frequency of rolandic spikes in ADHD children. Epilepsia 2004;45(5):564–5.; Dunn D.W., Austin J.K., Harezlak J., Ambrosius W.T. ADHD and epilepsy in childhood. Dev Med Child Neurol 2003;45(1):50–4.; Dunn D.W., Kronenberger W.G. Childhood epilepsy, attention problems, and ADHD: review and practical considerations. Semin Pediatr Neurol 2005;12(4):222–8.; Escobar R., Schacht A., Wehmeier P.M., Wagner T. Quality of life and attention-deficit/ hyperactivity disorder core symptoms: a pooled analysis of 5 non-US atomoxetine clinical trials. J Clin Psychopharmacol 2010;30(2):145–51.; Fernández-Mayoralas D.M., FernándezJaén A., Muñoz-Jareño N. et al. Effectiveness of levetiracetam in a patient with chronic motor tics, Rolandic epilepsy and attentional and behavioural disorder. Rev Neurol 2009;49(9):502–3.; Gertrude H. ADHD as a risk factor for incident unprovoked seizures and epilepsy in children. Arch Gen Psychiatry 2004;61(7):731–6.; Gonzalez-Heydrich J., Dodds A., Whitney J. et al. Psychiatric disorders and behavioral characteristics of pediatric patients with both epilepsy and attention-deficit hyperactivity disorder. Epilepsy Behav 2007;10(3):384–8.; Hamoda H.M., Guild D.J., Gumlak S. et al. Association between attention-deficit/ hyperactivity disorder and epilepsy in pediatric populations. Expert Rev Neurother 2009;9(12):1747–54.; Hechtman L., Weiss G. Long-term outcome of hyperactive children. Am J Orthopsychiatry 1983;53(3):532–41.; Heil S.H., Holmes H.W., Bickel W.K. et al. Comparison of the subjective, physiological, and psychomotor effects of atomoxetine and methylphenidate in light drug users. Drug Alcohol Depend 2002;67(2):149–56.; Hemmer S.A., Pasternak J.F., Zecker S.G., Trommer B.L. Stimulant therapy and seizure risk in children with ADHD. Pediatr Neurol 2001;24(2):99–102.; Hermann B., Jones J., Dabbs K. et al. The frequency, complications and aetiology of ADHD in new onset paediatric epilepsy. Brain 2007;130(Pt 12):3135–48.; Hesdorffer D.C., Ludvigsson P., Olafsson E. et al. ADHD as a risk factor for incident unprovoked seizures and epilepsy in children. Arch Gen Psychiatry 2004;61(7):731–6.; Hoffman H. Der struwwelpeter. Esslinger, 2014. 20 p.; Ibekwe R.C., Chidi N.A., Ebele A.A., Chinyelu O.N. Co-morbidity of attention deficit hyperactivity disorder (ADHD) and epilepsy in children seen in University of Nigeria Teaching Hospital Enugu: prevalence, clinical and social correlates. Niger Postgrad Med J 2014;21(4):273–8.; Inaba Y., Seki C., Ogiwara Y. et al. Supplementary motor area epilepsy associated with ADHD in an abused history. No To Hattatsu 2000;32(5):435–9.; Kaminow L., Schimschock J.R., Hammer A.E., Vuong A. Lamotrigine monotherapy compared with carbamazepine, phenytoin, or valproate monotherapy in patients with epilepsy. Epilepsy Behav 2003;4(6):659–66.; Kang S.H., Yum M.S., Kim E.H. et al. Cognitive function in childhood epilepsy: importance of attention deficit hyperactivity disorder. J Clin Neurol 2015;11(1):20–5.; Kanner A.M. The use of psychotropic drugs in epilepsy: what every neurologist should know. Semin Neurol 2008;28(3):379–88.; Kaufmann R., Goldberg-Stern H., Shuper A. Attention-deficit disorders and epilepsy in childhood: incidence, causative relations and treatment possibilities. J Child Neurol 2009;24(6):727–33.; Kinney R.O., Shaywitz B.A., Shaywitz S.E. et al. Epilepsy in children with attention deficit disorder: cognitive, behavioral, and neuroanatomic indices. Pediatr Neurol 1990;6(1):31–7.; Klassen A.F., Miller A., Fine S. Healthrelated quality of life in children and adolescents who have a diagnosis of attentiondeficit/hyperactivity disorder. Pediatrics 2004;114(5):541–7.; Koneski J.A., Casella E.B. Attention deficit and hyperactivity disorder in people with epilepsy: diagnosis and implications to the treatment. Arq Neuropsiquiatr 2010;68(1):107–14.; Laporte N., Sebire G., Gillerot Y. et al. Cognitive epilepsy: ADHD related to focal EEG discharges. Pediatr Neurol 2002;27(4):307–11.; Lehmkuhl G., Sevecke K., Frohlich J., Dopfner M. Child is inattentive, cannot sit still, disturbs the classroom. Is it really a hyperkinetic disorder? MMW Fortschr Med 2002;144(47):26–31.; Liu S.T., Tsai F.J., Lee W.T. et al. Attentional processes and ADHD-related symptoms in pediatric patients with epilepsy. Epilepsy Res 2011;93(1):53–65.; Marson A.G., Al-Kharusi A.M., Alwaidh M. et al. The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial. Lancet 2007;369(9566):1000–15.; Mula M., Sander J.W. Negative effects of antiepileptic drugs on mood in patients with epilepsy. Drug Saf 2007;30(7):555–67.; Mulas F., Tellez de Meneses M., Hernandez-Muela S. et al. Attention deficit hyperactivity disorder and epilepsy. Rev Neurol 2004;39(2):192–5.; Nieto-Barrera M., Brozmanova M., Capovilla G. et al.; Lamictal vs. Carbamazepine Study Group. A comparison of monotherapy with lamotrigine or carbamazepine in patients with newly diagnosed partial epilepsy. Epilepsy Res 2001;46(2):145–55.; Ottman R., Lipton R.B., Ettinger A.B. et al. Comorbidities of epilepsy: results from the Epilepsy Comorbidities and Health (EPIC) Survey. Epilepsia 2011;52(2):308–15.; Parisi P., Moavero R., Verrotti A., Curatolo P. Attention deficit hyperactivity disorder in children with epilepsy. Brain Dev 2010;32(1):10–6.; Pearl P.L., Weiss R.E., Stein M.A. Medical mimics. Medical and neurological conditions simulating ADHD. Ann NY Acad Sci 2001;931:97–112.; Powell A.L., Yudd A., Zee P., Mandelbaum D.E. Attention deficit hyperactivity disorder associated with orbitofrontal epilepsy in a father and a son. Neuropsychiatry Neuropsychol Behav Neurol 1997;10(2):151–4.; Rasmussen N.H., Hansen L.K., Sahlholdt L. Comorbidity in children with epilepsy. I: Behaviour problems, ADHD and intelligence. Ugeskr Laeger 2007;169(19):1767–70.; Rugino T.A., Samsock T.C. Levetiracetam in autistic children: an open-label study. J Dev Behav Pediatr 2002;23(4):225–30.; Schubert R. Attention deficit disorder and epilepsy. Pediatr Neurol 2005;32(1):1–10.; Seidenberg M., Pulsipher D.T., Hermann B. Association of epilepsy and comorbid conditions. Future Neurol 2009;4(5):663–8.; Semrud-Clikeman M., Wical B. Components of attention in children with complex partial seizures with and without ADHD. Epilepsia 1999;40(2):211–5.; Sherman E.M., Slick D.J., Connolly M.B., Eyrl K.L. ADHD, neurological correlates and health-related quality of life in severe pediatric epilepsy. Epilepsia 2007;48(6):1083–91.; Sinclair D.B., Unwala H. Absence epilepsy in childhood: electroencephalography (EEG) does not predict outcome. J Child Neurol 2007;22(7):799–802.; Sinzig J.K., von Gontard A. Absences as differential diagnosis in children with attention-deficit disorder. Klin Padiatr 2005;217(4):230–3.; Socanski D., Herigstad A., Thomsen P.H. et al. Epileptiform abnormalities in children diagnosed with attention deficit/hyperactivity disorder. Epilepsy Behav 2010;19(3):483–6.; Tan M., Appleton R. Attention deficit and hyperactivity disorder, methylphenidate, and epilepsy. Arch Dis Child 2005;90(1): 57–9.; Torres A.R., Whitney J., GonzalezHeydrich J. Attention-deficit/hyperactivity disorder in pediatric patients with epilepsy: review of pharmacological treatment. Epilepsy Behav 2008;12(2):217–33.; Torres A., Whitney J., Rao S. et al. Tolerability of atomoxetine for treatment of pediatric attention-deficit/hyperactivity disorder in the context of epilepsy. Epilepsy Behav 2011;20(1):95–102.; Van der Feltz-Cornelis C.M., Aldenkamp A.P. Effectiveness and safety of methylphenidate in adult attention deficit hyperactivity disorder in patients with epilepsy: an open treatment trial. Epilepsy Behav 2006;8(3):659–62.; Vega C., Vestal M., DeSalvo M. et al. Differentiation of attention-related problems in childhood absence epilepsy. Epilepsy Behav 2010;19(1):82–5.; Weinstock A., Giglio P., Kerr S.L. et al. Hyperkinetic seizures in children. J Child Neurol 2003;18(8):517–24.; Wernicke J.F., Holdridge K.C., Jin L. et al. Seizure risk in patients with attention-deficithyperactivity disorder treated with atomoxetine. Dev Med Child Neurol 2007;49(7):498–502.; Wisniewska B., Baranowska W., Wendorff J. The assessment of comorbid disorders in ADHD children and adolescents. Adv Med Sci 2007;52 Suppl 1: 215–7.; Young J. Common comorbidities seen in adolescents with attention-deficit/ hyperactivity disorder. Adolesc Med State Art Rev 2008;19(2):216–28.; Zhang Z., Lu G., Zhong Y. et al. Impaired attention network in temporal lobe epilepsy: a resting FMRI study. Neurosci Lett 2009;458(3):97–101.; https://rjdn.abvpress.ru/jour/article/view/57

  12. 12
    Academic Journal

    Source: Russian Journal of Child Neurology; Том 10, № 2 (2015); 54-58 ; Русский журнал детской неврологии; Том 10, № 2 (2015); 54-58 ; 2412-9178 ; 2073-8803 ; 10.17650/2073-8803-2015-10-2

    File Description: application/pdf

    Relation: https://rjdn.abvpress.ru/jour/article/view/56/52; Андрущенко Н.В. Монтессори-педагогика и Монтессори-терапия. СПб.: Речь, 2010. 316 с. [Andruschenko N.V. Montessori education and Montessori therapy. Saint Petersburg: Rech, 2010. 316 p. (In Russ.)].; Брязгунов И.П., Касатикова Е.В. Непоседливый ребенок. М.: Издательство Института психиатрии, 2001. [Bryazgunov I.P., Kasatikova Е.V. Fidgety сhild. Moscow: Publishing House of Psychiatry Institute, 2001. (In Russ.)].; Горбачевская Н.Л., Заваденко Н.Н., Сорокин А.Б., Григорьева Н.В. Нейрофизиологическое исследование синдрома дефицита внимания с гиперактивностью. Сибирский вестник психиатрии и наркологии 2003;(1):47–51. [Gorbachevskaya N.L., Zavadenko N.N., Sorokin А.V., Grigoryeva N.V. Neurophysiological research of attention deficit hyperactivity disorder. Sibirskiy vestnik psikhiatrii i narkologii = Siberian Bulletin of Psychiatry and Addiction Medicine 2003;(1):47–51. (In Russ.)].; Заваденко Н.Н. Гиперактивность и дефицит внимания в детском возрасте. М.: Академия, 2005. 256 с. [Zavadenko N.N. Hyperactivity and attention deficit in childhood. Moscow: Academy, 2005. 256 p. (In Russ.)].; Кучма В.Р., Платонова А.Г. Дефицит внимания с гиперактивностью у детей России: распространенность, факторы риска и профилактика. М.: Рарогъ, 1997. [Kuchma V.Р., Platonova A.G. Attention deficit hyperactivity disorder in Russian children: prevalence, risk factors and prevention. Moscow: Rarog, 1997. (In Russ.)].; Тугой И.А. Психологические методы в образовании с Effecton Studio. Липецк: ЛЭГИ, 2006. [Tugoy I.A. Psychological methods in education with effecton studio. Lipetsk: LEGI, 2006. (In Russ.)].; Barkley R.A., Fischer M., Smallish L., Fletcher K. Young adult outcome of hyperactive children: adaptive functioning in major life activities. J Am Acad Child Adolesc Psychiatry 2006;45(2):192–202.; Biederman J., Faraone S.V. Attention deficit hyperactivity disorder. Lancet 2005;366(9481):237–48.; Furman L. What is attention-deficit hyperactivity disorder (ADHD)? J Child Neurol 2005;20(12):994–1002.; Ruchkin V. et al. Attention-deficit/ hyperactivity symptoms and associated psychopathology in a community sample of Russian adolescents. New Haven: CT, 2006.; Swanson J.M., Sergeant J.A., Taylor E. et al. Attention-deficit hyperactivity disorder and hyperkinetic disorder. Lancet 1998;351(9100):429–33.; Thapar A., O'Donovan M., Owen M.J. The genetics of attention deficit hyperactivity disorder. Hum Mol Genet 2005;14 Spec No 2: R275–82.; Weiss M., Tannock R., Kratochvil Ch. et al. A randomized, placebo-controlled study of once-daily atomoxetine in the school setting in children with ADHD. J Am Acad Child Adol Psychiatry 2005;44(7):647–55.; Zametkin A.J., Ernst M. Problems in the management of attention-deficithyperactivity disorder. N Engl J Med 1999;340(1):40–6.; https://rjdn.abvpress.ru/jour/article/view/56

  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20